Home › Compare › IFUS vs JNJ

IFUS vs JNJ: Dividend Comparison 2026

IFUS yields 8492.57% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 IFUS wins by $11041986035131172.00M in total portfolio value
10 years
IFUS
IFUS
● Live price
8492.57%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$11041986035131172.00M
Annual income
$10,792,008,505,664,056,000,000.00
Full IFUS calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — IFUS vs JNJ

📍 IFUS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodIFUSJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, IFUS + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
IFUS pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

IFUS
Annual income on $10K today (after 15% tax)
$721,868.37/yr
After 10yr DRIP, annual income (after tax)
$9,173,207,229,814,447,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, IFUS beats the other by $9,173,207,229,814,447,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of IFUS + JNJ for your $10,000?

IFUS: 50%JNJ: 50%
100% JNJ50/50100% IFUS
Portfolio after 10yr
$5520993017565586.00M
Annual income
$5,396,004,252,832,028,000,000.00/yr
Blended yield
97.74%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

IFUS
No analyst data
Altman Z
7.4
Piotroski
5/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

IFUS buys
0
JNJ buys
0
No recent congressional trades found for IFUS or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricIFUSJNJ
Forward yield8492.57% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$11041986035131172.00M ✓$20.0K
Annual income after 10y$10,792,008,505,664,056,000,000.00 ✓$827.78
Total dividends collected$11025302406276466.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: IFUS vs JNJ ($10,000, DRIP)

YearIFUS PortfolioIFUS Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$859,957$849,256.90$10,676$355.77+$849.3K → IFUS
2$69,174,764$68,254,610.41$11,407$389.39+$69.16M → IFUS
3$5,205,220,238$5,131,203,240.18$12,198$426.53+$5205.21M → IFUS
4$366,419,711,261$360,850,125,605.98$13,056$467.62+$366419.70M → IFUS
5$24,132,183,173,475$23,740,114,082,425.72$13,987$513.12+$24132183.16M → IFUS
6$1,487,045,477,053,427$1,461,224,041,057,809.20$14,998$563.56+$1487045477.04M → IFUS
7$85,742,407,458,414,640$84,151,268,797,967,470.00$16,098$619.52+$85742407458.40M → IFUS
8$4,626,441,795,368,287,000$4,534,697,419,387,782,700.00$17,295$681.69+$4626441795368.27M → IFUS
9$233,623,859,315,062,280,000$228,673,566,594,018,200,000.00$18,599$750.82+$233623859315062.25M → IFUS
10$11,041,986,035,131,173,000,000$10,792,008,505,664,056,000,000.00$20,022$827.78+$11041986035131172.00M → IFUS

IFUS vs JNJ: Complete Analysis 2026

IFUS — Stock

Impact Fusion International, Inc. engages in the business of marketing products in the health and wellness sector. The company focuses on the invention, development, and marketing of its proprietary products worldwide for the health of humans and animals. The company's products include Nutri-Mastic that supports digestive function, the immune system, vital organ health, healthy blood cells, and cardiac muscle and heart function; Intact Nutrition herbal health support products; Intact Endurance, which offers nutrients to increase body's optimal energy levels; Pet Intact nutritional supplements; and Equine Intact products. It also sells herbal health support beverages under the Mastic Blast Beverage brand; and alternative proprietary formulation for beef and dairy cattle under the Supreme Gold Plus brand. The company was formerly known as Red Reef Laboratories International, Inc. and changed its name to Impact Fusion International Inc. in April 2009. Impact Fusion International, Inc. was founded in 2002 and is based in Margate, Florida.

Full IFUS Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this IFUS vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

IFUS vs SCHDIFUS vs JEPIIFUS vs OIFUS vs KOIFUS vs MAINIFUS vs ABBVIFUS vs MRKIFUS vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.